DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $935,594 | -52.0% | 73,553 | -46.9% | 0.00% | -33.3% |
| Q2 2023 | $1,949,108 | -14.4% | 138,431 | -6.1% | 0.00% | -25.0% |
| Q1 2023 | $2,278,241 | +51.5% | 147,459 | +60.7% | 0.00% | +33.3% |
| Q4 2022 | $1,504,192 | +192.1% | 91,775 | +229.6% | 0.00% | +200.0% |
| Q3 2022 | $515,000 | +63.5% | 27,848 | +16.2% | 0.00% | 0.0% |
| Q2 2022 | $315,000 | -2.8% | 23,960 | -31.5% | 0.00% | – |
| Q1 2022 | $324,000 | +114.6% | 34,960 | +125.5% | 0.00% | – |
| Q4 2021 | $151,000 | – | 15,503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,086,723 | $85,910,000 | 25.70% |
| SV Health Investors, LLC | 449,951 | $18,525,000 | 15.54% |
| Redmile Group, LLC | 5,116,263 | $210,637,000 | 5.90% |
| Eversept Partners, LP | 414,081 | $17,047,715 | 4.24% |
| Sunesis Advisors, LLC | 96,299 | $3,965,000 | 3.99% |
| Avoro Capital Advisors LLC | 2,000,000 | $82,340,000 | 2.78% |
| Opaleye Management Inc. | 222,000 | $9,140,000 | 2.42% |
| SECTORAL ASSET MANAGEMENT INC | 204,059 | $8,401,000 | 1.61% |
| Artal Group S.A. | 800,000 | $32,936,000 | 1.39% |
| Atika Capital Management LLC | 141,000 | $5,805,000 | 1.11% |